 | • レポートコード：MRC2-11QY07195 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、189ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は生活改善薬のグローバル市場について調査・分析したレポートです。種類別（うつ病、皮膚科、性機能障害、肥満）市場規模、用途別（子供、大人、高齢者）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別生活改善薬の競争状況、市場シェア ・世界の生活改善薬市場：種類別市場規模 2015年-2020年（うつ病、皮膚科、性機能障害、肥満） ・世界の生活改善薬市場：種類別市場規模予測 2021年-2026年（うつ病、皮膚科、性機能障害、肥満） ・世界の生活改善薬市場：用途別市場規模 2015年-2020年（子供、大人、高齢者） ・世界の生活改善薬市場：用途別市場規模予測 2021年-2026年（子供、大人、高齢者） ・北米の生活改善薬市場分析：米国、カナダ ・ヨーロッパの生活改善薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの生活改善薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の生活改善薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの生活改善薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Allergan、BMS、Eli Lilly、Pfizer、Acerus Pharmaceuticals、Alkermes、Amorepacific、AndroScience、Anterios、AstraZeneca、Avanir Pharmaceuticals、Avolynt、Celtaxsys、Cerecor、Corcept Therapeutics、Cosmo Pharmaceuticals、CTC Bio、Dermira、Dong-A ST、Euthymics Bioscience、Foamix、Follicum、Forendo Pharma、Futura Medical Developments、Galderma ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Lifestyle drug is an term commonly applied to medications which treat non–life-threatening and non-painful conditions such as baldness, wrinkles, erectile dysfunction, or acne, which the speaker perceives as either not medical problems at all or as minor medical conditions relative to others. Proponents point out that improving the patient’s subjective quality of life has always been a primary concern of medicine.
There is direct impact of lifestyle drugs on society, particularly in the developing world. Implications associated with labeling of indications and products sales of these lifestyle drugs may be varied. Drugs can, over time, switch from ‘lifestyle’ to ‘mainstream’ use.
Market Analysis and Insights: Global Lifestyle Drugs Market
The global Lifestyle Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Lifestyle Drugs Scope and Market Size
Lifestyle Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Lifestyle Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Lifestyle Drugs market is segmented into
Depression
Dermatology
Sexual dysfunction
Obesity
Segment by Application, the Lifestyle Drugs market is segmented into
Children
Adults
Senior Citizens
Regional and Country-level Analysis
The Lifestyle Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Lifestyle Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Lifestyle Drugs Market Share Analysis
Lifestyle Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Lifestyle Drugs business, the date to enter into the Lifestyle Drugs market, Lifestyle Drugs product introduction, recent developments, etc.
The major vendors covered:
Allergan
BMS
Eli Lilly
Pfizer
Acerus Pharmaceuticals
Alkermes
Amorepacific
AndroScience
Anterios
AstraZeneca
Avanir Pharmaceuticals
Avolynt
Celtaxsys
Cerecor
Corcept Therapeutics
Cosmo Pharmaceuticals
CTC Bio
Dermira
Dong-A ST
Euthymics Bioscience
Foamix
Follicum
Forendo Pharma
Futura Medical Developments
Galderma
1 Study Coverage
1.1 Lifestyle Drugs Product Introduction
1.2 Market Segments
1.3 Key Lifestyle Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Lifestyle Drugs Market Size Growth Rate by Type
1.4.2 Depression
1.4.3 Dermatology
1.4.4 Sexual dysfunction
1.4.5 Obesity
1.5 Market by Application
1.5.1 Global Lifestyle Drugs Market Size Growth Rate by Application
1.5.2 Children
1.5.3 Adults
1.5.4 Senior Citizens
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Lifestyle Drugs Market Size, Estimates and Forecasts
2.1.1 Global Lifestyle Drugs Revenue 2015-2026
2.1.2 Global Lifestyle Drugs Sales 2015-2026
2.2 Global Lifestyle Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Lifestyle Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Lifestyle Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Lifestyle Drugs Competitor Landscape by Players
3.1 Lifestyle Drugs Sales by Manufacturers
3.1.1 Lifestyle Drugs Sales by Manufacturers (2015-2020)
3.1.2 Lifestyle Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Lifestyle Drugs Revenue by Manufacturers
3.2.1 Lifestyle Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Lifestyle Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Lifestyle Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Lifestyle Drugs Revenue in 2019
3.2.5 Global Lifestyle Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Lifestyle Drugs Price by Manufacturers
3.4 Lifestyle Drugs Manufacturing Base Distribution, Product Types
3.4.1 Lifestyle Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Lifestyle Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Lifestyle Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Lifestyle Drugs Market Size by Type (2015-2020)
4.1.1 Global Lifestyle Drugs Sales by Type (2015-2020)
4.1.2 Global Lifestyle Drugs Revenue by Type (2015-2020)
4.1.3 Lifestyle Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Lifestyle Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Lifestyle Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Lifestyle Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Lifestyle Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Lifestyle Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Lifestyle Drugs Market Size by Application (2015-2020)
5.1.1 Global Lifestyle Drugs Sales by Application (2015-2020)
5.1.2 Global Lifestyle Drugs Revenue by Application (2015-2020)
5.1.3 Lifestyle Drugs Price by Application (2015-2020)
5.2 Lifestyle Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Lifestyle Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Lifestyle Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Lifestyle Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Lifestyle Drugs by Country
6.1.1 North America Lifestyle Drugs Sales by Country
6.1.2 North America Lifestyle Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Lifestyle Drugs Market Facts & Figures by Type
6.3 North America Lifestyle Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Lifestyle Drugs by Country
7.1.1 Europe Lifestyle Drugs Sales by Country
7.1.2 Europe Lifestyle Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Lifestyle Drugs Market Facts & Figures by Type
7.3 Europe Lifestyle Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Lifestyle Drugs by Region
8.1.1 Asia Pacific Lifestyle Drugs Sales by Region
8.1.2 Asia Pacific Lifestyle Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Lifestyle Drugs Market Facts & Figures by Type
8.3 Asia Pacific Lifestyle Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Lifestyle Drugs by Country
9.1.1 Latin America Lifestyle Drugs Sales by Country
9.1.2 Latin America Lifestyle Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Lifestyle Drugs Market Facts & Figures by Type
9.3 Central & South America Lifestyle Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Lifestyle Drugs by Country
10.1.1 Middle East and Africa Lifestyle Drugs Sales by Country
10.1.2 Middle East and Africa Lifestyle Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Lifestyle Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Lifestyle Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 Allergan
11.1.1 Allergan Corporation Information
11.1.2 Allergan Description and Business Overview
11.1.3 Allergan Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Allergan Lifestyle Drugs Products Offered
11.1.5 Allergan Related Developments
11.2 BMS
11.2.1 BMS Corporation Information
11.2.2 BMS Description and Business Overview
11.2.3 BMS Sales, Revenue and Gross Margin (2015-2020)
11.2.4 BMS Lifestyle Drugs Products Offered
11.2.5 BMS Related Developments
11.3 Eli Lilly
11.3.1 Eli Lilly Corporation Information
11.3.2 Eli Lilly Description and Business Overview
11.3.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Eli Lilly Lifestyle Drugs Products Offered
11.3.5 Eli Lilly Related Developments
11.4 Pfizer
11.4.1 Pfizer Corporation Information
11.4.2 Pfizer Description and Business Overview
11.4.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Pfizer Lifestyle Drugs Products Offered
11.4.5 Pfizer Related Developments
11.5 Acerus Pharmaceuticals
11.5.1 Acerus Pharmaceuticals Corporation Information
11.5.2 Acerus Pharmaceuticals Description and Business Overview
11.5.3 Acerus Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Acerus Pharmaceuticals Lifestyle Drugs Products Offered
11.5.5 Acerus Pharmaceuticals Related Developments
11.6 Alkermes
11.6.1 Alkermes Corporation Information
11.6.2 Alkermes Description and Business Overview
11.6.3 Alkermes Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Alkermes Lifestyle Drugs Products Offered
11.6.5 Alkermes Related Developments
11.7 Amorepacific
11.7.1 Amorepacific Corporation Information
11.7.2 Amorepacific Description and Business Overview
11.7.3 Amorepacific Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Amorepacific Lifestyle Drugs Products Offered
11.7.5 Amorepacific Related Developments
11.8 AndroScience
11.8.1 AndroScience Corporation Information
11.8.2 AndroScience Description and Business Overview
11.8.3 AndroScience Sales, Revenue and Gross Margin (2015-2020)
11.8.4 AndroScience Lifestyle Drugs Products Offered
11.8.5 AndroScience Related Developments
11.9 Anterios
11.9.1 Anterios Corporation Information
11.9.2 Anterios Description and Business Overview
11.9.3 Anterios Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Anterios Lifestyle Drugs Products Offered
11.9.5 Anterios Related Developments
11.10 AstraZeneca
11.10.1 AstraZeneca Corporation Information
11.10.2 AstraZeneca Description and Business Overview
11.10.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.10.4 AstraZeneca Lifestyle Drugs Products Offered
11.10.5 AstraZeneca Related Developments
11.1 Allergan
11.1.1 Allergan Corporation Information
11.1.2 Allergan Description and Business Overview
11.1.3 Allergan Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Allergan Lifestyle Drugs Products Offered
11.1.5 Allergan Related Developments
11.12 Avolynt
11.12.1 Avolynt Corporation Information
11.12.2 Avolynt Description and Business Overview
11.12.3 Avolynt Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Avolynt Products Offered
11.12.5 Avolynt Related Developments
11.13 Celtaxsys
11.13.1 Celtaxsys Corporation Information
11.13.2 Celtaxsys Description and Business Overview
11.13.3 Celtaxsys Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Celtaxsys Products Offered
11.13.5 Celtaxsys Related Developments
11.14 Cerecor
11.14.1 Cerecor Corporation Information
11.14.2 Cerecor Description and Business Overview
11.14.3 Cerecor Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Cerecor Products Offered
11.14.5 Cerecor Related Developments
11.15 Corcept Therapeutics
11.15.1 Corcept Therapeutics Corporation Information
11.15.2 Corcept Therapeutics Description and Business Overview
11.15.3 Corcept Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Corcept Therapeutics Products Offered
11.15.5 Corcept Therapeutics Related Developments
11.16 Cosmo Pharmaceuticals
11.16.1 Cosmo Pharmaceuticals Corporation Information
11.16.2 Cosmo Pharmaceuticals Description and Business Overview
11.16.3 Cosmo Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Cosmo Pharmaceuticals Products Offered
11.16.5 Cosmo Pharmaceuticals Related Developments
11.17 CTC Bio
11.17.1 CTC Bio Corporation Information
11.17.2 CTC Bio Description and Business Overview
11.17.3 CTC Bio Sales, Revenue and Gross Margin (2015-2020)
11.17.4 CTC Bio Products Offered
11.17.5 CTC Bio Related Developments
11.18 Dermira
11.18.1 Dermira Corporation Information
11.18.2 Dermira Description and Business Overview
11.18.3 Dermira Sales, Revenue and Gross Margin (2015-2020)
11.18.4 Dermira Products Offered
11.18.5 Dermira Related Developments
11.19 Dong-A ST
11.19.1 Dong-A ST Corporation Information
11.19.2 Dong-A ST Description and Business Overview
11.19.3 Dong-A ST Sales, Revenue and Gross Margin (2015-2020)
11.19.4 Dong-A ST Products Offered
11.19.5 Dong-A ST Related Developments
11.20 Euthymics Bioscience
11.20.1 Euthymics Bioscience Corporation Information
11.20.2 Euthymics Bioscience Description and Business Overview
11.20.3 Euthymics Bioscience Sales, Revenue and Gross Margin (2015-2020)
11.20.4 Euthymics Bioscience Products Offered
11.20.5 Euthymics Bioscience Related Developments
11.21 Foamix
11.21.1 Foamix Corporation Information
11.21.2 Foamix Description and Business Overview
11.21.3 Foamix Sales, Revenue and Gross Margin (2015-2020)
11.21.4 Foamix Products Offered
11.21.5 Foamix Related Developments
11.22 Follicum
11.22.1 Follicum Corporation Information
11.22.2 Follicum Description and Business Overview
11.22.3 Follicum Sales, Revenue and Gross Margin (2015-2020)
11.22.4 Follicum Products Offered
11.22.5 Follicum Related Developments
11.23 Forendo Pharma
11.23.1 Forendo Pharma Corporation Information
11.23.2 Forendo Pharma Description and Business Overview
11.23.3 Forendo Pharma Sales, Revenue and Gross Margin (2015-2020)
11.23.4 Forendo Pharma Products Offered
11.23.5 Forendo Pharma Related Developments
11.24 Futura Medical Developments
11.24.1 Futura Medical Developments Corporation Information
11.24.2 Futura Medical Developments Description and Business Overview
11.24.3 Futura Medical Developments Sales, Revenue and Gross Margin (2015-2020)
11.24.4 Futura Medical Developments Products Offered
11.24.5 Futura Medical Developments Related Developments
11.25 Galderma
11.25.1 Galderma Corporation Information
11.25.2 Galderma Description and Business Overview
11.25.3 Galderma Sales, Revenue and Gross Margin (2015-2020)
11.25.4 Galderma Products Offered
11.25.5 Galderma Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Lifestyle Drugs Market Estimates and Projections by Region
12.1.1 Global Lifestyle Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Lifestyle Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Lifestyle Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Lifestyle Drugs Sales Forecast (2021-2026)
12.2.2 North America: Lifestyle Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Lifestyle Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Lifestyle Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Lifestyle Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Lifestyle Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Lifestyle Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Lifestyle Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Lifestyle Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Lifestyle Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Lifestyle Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Lifestyle Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Lifestyle Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Lifestyle Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Lifestyle Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Lifestyle Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Lifestyle Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Lifestyle Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Lifestyle Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Lifestyle Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Lifestyle Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Lifestyle Drugs Market Segments
Table 2. Ranking of Global Top Lifestyle Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Lifestyle Drugs Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Depression
Table 5. Major Manufacturers of Dermatology
Table 6. Major Manufacturers of Sexual dysfunction
Table 7. Major Manufacturers of Obesity
Table 8. Global Lifestyle Drugs Market Size Growth Rate by Application 2020-2026 (K Units)
Table 9. Global Lifestyle Drugs Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 10. Global Lifestyle Drugs Sales by Regions 2015-2020 (K Units)
Table 11. Global Lifestyle Drugs Sales Market Share by Regions (2015-2020)
Table 12. Global Lifestyle Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Lifestyle Drugs Sales by Manufacturers (2015-2020) (K Units)
Table 14. Global Lifestyle Drugs Sales Share by Manufacturers (2015-2020)
Table 15. Global Lifestyle Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Lifestyle Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lifestyle Drugs as of 2019)
Table 17. Lifestyle Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Lifestyle Drugs Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Lifestyle Drugs Price (2015-2020) (USD/Unit)
Table 20. Lifestyle Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Lifestyle Drugs Product Type
Table 22. Date of International Manufacturers Enter into Lifestyle Drugs Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Lifestyle Drugs Sales by Type (2015-2020) (K Units)
Table 25. Global Lifestyle Drugs Sales Share by Type (2015-2020)
Table 26. Global Lifestyle Drugs Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Lifestyle Drugs Revenue Share by Type (2015-2020)
Table 28. Lifestyle Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 29. Global Lifestyle Drugs Sales by Application (2015-2020) (K Units)
Table 30. Global Lifestyle Drugs Sales Share by Application (2015-2020)
Table 31. North America Lifestyle Drugs Sales by Country (2015-2020) (K Units)
Table 32. North America Lifestyle Drugs Sales Market Share by Country (2015-2020)
Table 33. North America Lifestyle Drugs Revenue by Country (2015-2020) (US$ Million)
Table 34. North America Lifestyle Drugs Revenue Market Share by Country (2015-2020)
Table 35. North America Lifestyle Drugs Sales by Type (2015-2020) (K Units)
Table 36. North America Lifestyle Drugs Sales Market Share by Type (2015-2020)
Table 37. North America Lifestyle Drugs Sales by Application (2015-2020) (K Units)
Table 38. North America Lifestyle Drugs Sales Market Share by Application (2015-2020)
Table 39. Europe Lifestyle Drugs Sales by Country (2015-2020) (K Units)
Table 40. Europe Lifestyle Drugs Sales Market Share by Country (2015-2020)
Table 41. Europe Lifestyle Drugs Revenue by Country (2015-2020) (US$ Million)
Table 42. Europe Lifestyle Drugs Revenue Market Share by Country (2015-2020)
Table 43. Europe Lifestyle Drugs Sales by Type (2015-2020) (K Units)
Table 44. Europe Lifestyle Drugs Sales Market Share by Type (2015-2020)
Table 45. Europe Lifestyle Drugs Sales by Application (2015-2020) (K Units)
Table 46. Europe Lifestyle Drugs Sales Market Share by Application (2015-2020)
Table 47. Asia Pacific Lifestyle Drugs Sales by Region (2015-2020) (K Units)
Table 48. Asia Pacific Lifestyle Drugs Sales Market Share by Region (2015-2020)
Table 49. Asia Pacific Lifestyle Drugs Revenue by Region (2015-2020) (US$ Million)
Table 50. Asia Pacific Lifestyle Drugs Revenue Market Share by Region (2015-2020)
Table 51. Asia Pacific Lifestyle Drugs Sales by Type (2015-2020) (K Units)
Table 52. Asia Pacific Lifestyle Drugs Sales Market Share by Type (2015-2020)
Table 53. Asia Pacific Lifestyle Drugs Sales by Application (2015-2020) (K Units)
Table 54. Asia Pacific Lifestyle Drugs Sales Market Share by Application (2015-2020)
Table 55. Latin America Lifestyle Drugs Sales by Country (2015-2020) (K Units)
Table 56. Latin America Lifestyle Drugs Sales Market Share by Country (2015-2020)
Table 57. Latin Americaa Lifestyle Drugs Revenue by Country (2015-2020) (US$ Million)
Table 58. Latin America Lifestyle Drugs Revenue Market Share by Country (2015-2020)
Table 59. Latin America Lifestyle Drugs Sales by Type (2015-2020) (K Units)
Table 60. Latin America Lifestyle Drugs Sales Market Share by Type (2015-2020)
Table 61. Latin America Lifestyle Drugs Sales by Application (2015-2020) (K Units)
Table 62. Latin America Lifestyle Drugs Sales Market Share by Application (2015-2020)
Table 63. Middle East and Africa Lifestyle Drugs Sales by Country (2015-2020) (K Units)
Table 64. Middle East and Africa Lifestyle Drugs Sales Market Share by Country (2015-2020)
Table 65. Middle East and Africa Lifestyle Drugs Revenue by Country (2015-2020) (US$ Million)
Table 66. Middle East and Africa Lifestyle Drugs Revenue Market Share by Country (2015-2020)
Table 67. Middle East and Africa Lifestyle Drugs Sales by Type (2015-2020) (K Units)
Table 68. Middle East and Africa Lifestyle Drugs Sales Market Share by Type (2015-2020)
Table 69. Middle East and Africa Lifestyle Drugs Sales by Application (2015-2020) (K Units)
Table 70. Middle East and Africa Lifestyle Drugs Sales Market Share by Application (2015-2020)
Table 71. Allergan Corporation Information
Table 72. Allergan Description and Major Businesses
Table 73. Allergan Lifestyle Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 74. Allergan Product
Table 75. Allergan Recent Development
Table 76. BMS Corporation Information
Table 77. BMS Description and Major Businesses
Table 78. BMS Lifestyle Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 79. BMS Product
Table 80. BMS Recent Development
Table 81. Eli Lilly Corporation Information
Table 82. Eli Lilly Description and Major Businesses
Table 83. Eli Lilly Lifestyle Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 84. Eli Lilly Product
Table 85. Eli Lilly Recent Development
Table 86. Pfizer Corporation Information
Table 87. Pfizer Description and Major Businesses
Table 88. Pfizer Lifestyle Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 89. Pfizer Product
Table 90. Pfizer Recent Development
Table 91. Acerus Pharmaceuticals Corporation Information
Table 92. Acerus Pharmaceuticals Description and Major Businesses
Table 93. Acerus Pharmaceuticals Lifestyle Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 94. Acerus Pharmaceuticals Product
Table 95. Acerus Pharmaceuticals Recent Development
Table 96. Alkermes Corporation Information
Table 97. Alkermes Description and Major Businesses
Table 98. Alkermes Lifestyle Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 99. Alkermes Product
Table 100. Alkermes Recent Development
Table 101. Amorepacific Corporation Information
Table 102. Amorepacific Description and Major Businesses
Table 103. Amorepacific Lifestyle Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 104. Amorepacific Product
Table 105. Amorepacific Recent Development
Table 106. AndroScience Corporation Information
Table 107. AndroScience Description and Major Businesses
Table 108. AndroScience Lifestyle Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 109. AndroScience Product
Table 110. AndroScience Recent Development
Table 111. Anterios Corporation Information
Table 112. Anterios Description and Major Businesses
Table 113. Anterios Lifestyle Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 114. Anterios Product
Table 115. Anterios Recent Development
Table 116. AstraZeneca Corporation Information
Table 117. AstraZeneca Description and Major Businesses
Table 118. AstraZeneca Lifestyle Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 119. AstraZeneca Product
Table 120. AstraZeneca Recent Development
Table 121. Avanir Pharmaceuticals Corporation Information
Table 122. Avanir Pharmaceuticals Description and Major Businesses
Table 123. Avanir Pharmaceuticals Lifestyle Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 124. Avanir Pharmaceuticals Product
Table 125. Avanir Pharmaceuticals Recent Development
Table 126. Avolynt Corporation Information
Table 127. Avolynt Description and Major Businesses
Table 128. Avolynt Lifestyle Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 129. Avolynt Product
Table 130. Avolynt Recent Development
Table 131. Celtaxsys Corporation Information
Table 132. Celtaxsys Description and Major Businesses
Table 133. Celtaxsys Lifestyle Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 134. Celtaxsys Product
Table 135. Celtaxsys Recent Development
Table 136. Cerecor Corporation Information
Table 137. Cerecor Description and Major Businesses
Table 138. Cerecor Lifestyle Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 139. Cerecor Product
Table 140. Cerecor Recent Development
Table 141. Corcept Therapeutics Corporation Information
Table 142. Corcept Therapeutics Description and Major Businesses
Table 143. Corcept Therapeutics Lifestyle Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 144. Corcept Therapeutics Product
Table 145. Corcept Therapeutics Recent Development
Table 146. Cosmo Pharmaceuticals Corporation Information
Table 147. Cosmo Pharmaceuticals Description and Major Businesses
Table 148. Cosmo Pharmaceuticals Lifestyle Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 149. Cosmo Pharmaceuticals Product
Table 150. Cosmo Pharmaceuticals Recent Development
Table 151. CTC Bio Corporation Information
Table 152. CTC Bio Description and Major Businesses
Table 153. CTC Bio Lifestyle Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 154. CTC Bio Product
Table 155. CTC Bio Recent Development
Table 156. Dermira Corporation Information
Table 157. Dermira Description and Major Businesses
Table 158. Dermira Lifestyle Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 159. Dermira Product
Table 160. Dermira Recent Development
Table 161. Dong-A ST Corporation Information
Table 162. Dong-A ST Description and Major Businesses
Table 163. Dong-A ST Lifestyle Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 164. Dong-A ST Product
Table 165. Dong-A ST Recent Development
Table 166. Euthymics Bioscience Corporation Information
Table 167. Euthymics Bioscience Description and Major Businesses
Table 168. Euthymics Bioscience Lifestyle Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 169. Euthymics Bioscience Product
Table 170. Euthymics Bioscience Recent Development
Table 171. Foamix Corporation Information
Table 172. Foamix Description and Major Businesses
Table 173. Foamix Lifestyle Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 174. Foamix Product
Table 175. Foamix Recent Development
Table 176. Follicum Corporation Information
Table 177. Follicum Description and Major Businesses
Table 178. Follicum Lifestyle Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 179. Follicum Product
Table 180. Follicum Recent Development
Table 181. Forendo Pharma Corporation Information
Table 182. Forendo Pharma Description and Major Businesses
Table 183. Forendo Pharma Lifestyle Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 184. Forendo Pharma Product
Table 185. Forendo Pharma Recent Development
Table 186. Futura Medical Developments Corporation Information
Table 187. Futura Medical Developments Description and Major Businesses
Table 188. Futura Medical Developments Lifestyle Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 189. Futura Medical Developments Product
Table 190. Futura Medical Developments Recent Development
Table 191. Galderma Corporation Information
Table 192. Galderma Description and Major Businesses
Table 193. Galderma Lifestyle Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 194. Galderma Product
Table 195. Galderma Recent Development
Table 196. Global Lifestyle Drugs Sales Forecast by Regions (2021-2026) (K Units)
Table 197. Global Lifestyle Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 198. Global Lifestyle Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 199. Global Lifestyle Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 200. North America: Lifestyle Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 201. North America: Lifestyle Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 202. Europe: Lifestyle Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 203. Europe: Lifestyle Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 204. Asia Pacific: Lifestyle Drugs Sales Forecast by Region (2021-2026) (K Units)
Table 205. Asia Pacific: Lifestyle Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 206. Latin America: Lifestyle Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 207. Latin America: Lifestyle Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 208. Middle East and Africa: Lifestyle Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 209. Middle East and Africa: Lifestyle Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 210. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 211. Key Challenges
Table 212. Market Risks
Table 213. Main Points Interviewed from Key Lifestyle Drugs Players
Table 214. Lifestyle Drugs Customers List
Table 215. Lifestyle Drugs Distributors List
Table 216. Research Programs/Design for This Report
Table 217. Key Data Information from Secondary Sources
Table 218. Key Data Information from Primary Sources
List of Figures
Figure 1. Lifestyle Drugs Product Picture
Figure 2. Global Lifestyle Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Depression Product Picture
Figure 4. Dermatology Product Picture
Figure 5. Sexual dysfunction Product Picture
Figure 6. Obesity Product Picture
Figure 7. Global Lifestyle Drugs Sales Market Share by Application in 2020 & 2026
Figure 8. Children
Figure 9. Adults
Figure 10. Senior Citizens
Figure 11. Lifestyle Drugs Report Years Considered
Figure 12. Global Lifestyle Drugs Market Size 2015-2026 (US$ Million)
Figure 13. Global Lifestyle Drugs Sales 2015-2026 (K Units)
Figure 14. Global Lifestyle Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Lifestyle Drugs Sales Market Share by Region (2015-2020)
Figure 16. Global Lifestyle Drugs Sales Market Share by Region in 2019
Figure 17. Global Lifestyle Drugs Revenue Market Share by Region (2015-2020)
Figure 18. Global Lifestyle Drugs Revenue Market Share by Region in 2019
Figure 19. Global Lifestyle Drugs Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Lifestyle Drugs Revenue in 2019
Figure 21. Lifestyle Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Lifestyle Drugs Sales Market Share by Type (2015-2020)
Figure 23. Global Lifestyle Drugs Sales Market Share by Type in 2019
Figure 24. Global Lifestyle Drugs Revenue Market Share by Type (2015-2020)
Figure 25. Global Lifestyle Drugs Revenue Market Share by Type in 2019
Figure 26. Global Lifestyle Drugs Market Share by Price Range (2015-2020)
Figure 27. Global Lifestyle Drugs Sales Market Share by Application (2015-2020)
Figure 28. Global Lifestyle Drugs Sales Market Share by Application in 2019
Figure 29. Global Lifestyle Drugs Revenue Market Share by Application (2015-2020)
Figure 30. Global Lifestyle Drugs Revenue Market Share by Application in 2019
Figure 31. North America Lifestyle Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 32. North America Lifestyle Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Lifestyle Drugs Sales Market Share by Country in 2019
Figure 34. North America Lifestyle Drugs Revenue Market Share by Country in 2019
Figure 35. U.S. Lifestyle Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 36. U.S. Lifestyle Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Lifestyle Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 38. Canada Lifestyle Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Lifestyle Drugs Market Share by Type in 2019
Figure 40. North America Lifestyle Drugs Market Share by Application in 2019
Figure 41. Europe Lifestyle Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 42. Europe Lifestyle Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Lifestyle Drugs Sales Market Share by Country in 2019
Figure 44. Europe Lifestyle Drugs Revenue Market Share by Country in 2019
Figure 45. Germany Lifestyle Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 46. Germany Lifestyle Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Lifestyle Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 48. France Lifestyle Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Lifestyle Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 50. U.K. Lifestyle Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Lifestyle Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 52. Italy Lifestyle Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Lifestyle Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 54. Russia Lifestyle Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Lifestyle Drugs Market Share by Type in 2019
Figure 56. Europe Lifestyle Drugs Market Share by Application in 2019
Figure 57. Asia Pacific Lifestyle Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 58. Asia Pacific Lifestyle Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Lifestyle Drugs Sales Market Share by Region in 2019
Figure 60. Asia Pacific Lifestyle Drugs Revenue Market Share by Region in 2019
Figure 61. China Lifestyle Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 62. China Lifestyle Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Lifestyle Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 64. Japan Lifestyle Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Lifestyle Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 66. South Korea Lifestyle Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Lifestyle Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 68. India Lifestyle Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Lifestyle Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 70. Australia Lifestyle Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Lifestyle Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 72. Taiwan Lifestyle Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Lifestyle Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 74. Indonesia Lifestyle Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Lifestyle Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 76. Thailand Lifestyle Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Lifestyle Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 78. Malaysia Lifestyle Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Lifestyle Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 80. Philippines Lifestyle Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Lifestyle Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 82. Vietnam Lifestyle Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Lifestyle Drugs Market Share by Type in 2019
Figure 84. Asia Pacific Lifestyle Drugs Market Share by Application in 2019
Figure 85. Latin America Lifestyle Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 86. Latin America Lifestyle Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Lifestyle Drugs Sales Market Share by Country in 2019
Figure 88. Latin America Lifestyle Drugs Revenue Market Share by Country in 2019
Figure 89. Mexico Lifestyle Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 90. Mexico Lifestyle Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Lifestyle Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 92. Brazil Lifestyle Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Lifestyle Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 94. Argentina Lifestyle Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Lifestyle Drugs Market Share by Type in 2019
Figure 96. Latin America Lifestyle Drugs Market Share by Application in 2019
Figure 97. Middle East and Africa Lifestyle Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 98. Middle East and Africa Lifestyle Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Lifestyle Drugs Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Lifestyle Drugs Revenue Market Share by Country in 2019
Figure 101. Turkey Lifestyle Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 102. Turkey Lifestyle Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Lifestyle Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 104. Saudi Arabia Lifestyle Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Lifestyle Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 106. U.A.E Lifestyle Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Lifestyle Drugs Market Share by Type in 2019
Figure 108. Middle East and Africa Lifestyle Drugs Market Share by Application in 2019
Figure 109. North America Lifestyle Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 110. North America Lifestyle Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Europe Lifestyle Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 112. Europe Lifestyle Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Asia Pacific Lifestyle Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 114. Asia Pacific Lifestyle Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Latin America Lifestyle Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 116. Latin America Lifestyle Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Middle East and Africa Lifestyle Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 118. Middle East and Africa Lifestyle Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Porter's Five Forces Analysis
Figure 120. Channels of Distribution
Figure 121. Distributors Profiles
Figure 122. Bottom-up and Top-down Approaches for This Report
Figure 123. Data Triangulation
Figure 124. Key Executives Interviewed
性機能障害治療薬の世界市場（～2026年） Sexual dysfunctions include sexual disorders of men and women that can interfere with their sexual performance, leading to unsatisfied sexual intercourse. The major drugs used in this market are PDE5 inhibitors, whereas other drugs such as hormone-related and transurethral also have a presence in th…- スマートウェアラブルライフスタイルデバイスの世界市場（～2026年） Smart wearable lifestyle devices are portable devices fastened on a user's body to measure the parameters related to their health and well-being helping them to take a proper decision regarding them. For instance, a wearable lifestyle device used to measure the quality of sleep helps in analyzing a …
- 抗肥満薬の世界市場（～2026年） Anti-obesity drugs are pharmacological agents that reduce or control weight. These drugs alter one of the fundamental processes of the human body, weight regulation, by altering either appetite, or absorption of calories. The main treatment modalities for overweight and obese individuals remain diet…
- 泌尿生殖器治療薬の世界市場（～2026年） A medical science concerned with the study and treatment of diseases of the genital and urinary organs, especially sexually transmitted diseases. The growing prevalence of genitourinary disorders is presumed to be the high rendering impact driver of this vertical. In addition, increasing number of p…
- 抗肥満薬（抗肥満薬）の世界市場（～2026年） Anti-obesity medication or weight loss medications are pharmacological agents that reduce or control weight. These medications alter one of the fundamental processes of the human body, weight regulation, by altering either appetite, or absorption of calories. Market Analysis and Insights: Global Ant…